Through dual encapsulation of the insecticide lufenuron with β-cyclodextrin octadecanoate and urea-formaldehyde resin, a lufenuron@β-cyclodextrin octadecanoate/urea formaldehyde resin (LF@β-CDs/UF) nanoformulation was prepared. This dual-carrier synergy significantly prolonged the release cycle of lufenuron and enhanced environmental adaptability. Results demonstrated that under 25 °C and pH 7 conditions, its release cycle reached 324 h in 20% methanol-water, representing a 1.5-fold prolongation compared to the single-carrier lufenuron@β-cyclodextrin octadecanoate (LF@β-CDs) nanoformulation, with a pH/temperature-responsive release behavior. The photolysis half-life (t₅₀) was extended by 1.6- and 9.3-fold compared to LF@β-CDs (51 h) and lufenuron (LF) microemulsion (8.9 h), respectively. At a low concentration of 6.25 mg/L, the mortality rate against Spodoptera litura reached 73.33%, significantly outperforming LF@β-CDs (29.33%) and LF microemulsion (5.33%). The LF@β-CDs/UF also substantially prolonged insecticidal duration and enhanced the systemic translocation of lufenuron in plants. Biosafety assessment showed that it significantly reduced ecological toxicity, increasing rice seed germination rates from 40.7% (microemulsion) to 71.3% at 400 mg/L seed-soaking concentration, while elevating the acute toxicity LC₅₀ value in zebrafish by 4.4-fold, demonstrating substantially comparative eco-friendliness compared to conventional formulations. This dual-carrier technology, via structure-function synergy, provides an innovative solution to challenges such as low pesticide utilization efficiency and high environmental risks.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: